Subgrouping immunomodulating β-glucans by monitoring IFN-γ and NO syntheses.
- Published in:
- Drug Development Research, 1997, v. 42, n. 1, p. 35, doi. 10.1002/(SICI)1098-2299(199709)42:1<35::AID-DDR3>3.0.CO;2-S
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 1997 AND VI 42 AND IP 1
Results: 4
1
2
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents.
- Published in:
- Drug Development Research, 1997, v. 42, n. 1, p. 26, doi. 10.1002/(SICI)1098-2299(199709)42:1<26::AID-DDR2>3.0.CO;2-T
- By:
- Publication type:
- Article
3
Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease.
- Published in:
- Drug Development Research, 1997, v. 42, n. 1, p. 1, doi. 10.1002/(SICI)1098-2299(199709)42:1<1::AID-DDR1>3.0.CO;2-I
- By:
- Publication type:
- Article
4
Pyrazolopyridines: Effect of structural alterations on activity at adenosine- and GABA<sub>A</sub>-receptors.
- Published in:
- Drug Development Research, 1997, v. 42, n. 1, p. 41, doi. 10.1002/(SICI)1098-2299(199709)42:1<41::AID-DDR4>3.0.CO;2-R
- By:
- Publication type:
- Article